Leo Ehrlich - 30 Dec 2022 Form 4 Insider Report for Innovation Pharmaceuticals Inc.

Reporting relationship
CEO and Chairman, Director
Issuer ticker
N/A
Reported as of
30 Dec 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Jan 2023, 15:15:14 UTC
Prior SEC filing
28 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leo Ehrlich

Key filing fact

Leo Ehrlich filed Form 4 for Innovation Pharmaceuticals Inc. on 04 Jan 2023.

Key facts

  • This page summarizes Leo Ehrlich's Form 4 filing for Innovation Pharmaceuticals Inc..
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 04 Jan 2023, 15:15.

Change

  • Previous filing in this sequence was filed on 28 Sep 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IPIX transaction Derivative

Class B Common Stock

Other

Transaction value
$0
Shares
-11,307,527
Change %
-72%
Price
$0.000000
Shares after
4,333,936
Date
30 Dec 2022
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
11,307,527
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, and has no expiration date.

Footnote F2

Represents the voluntary surrender, without consideration, to the registrant of 11,307,527 shares of Class B Common Stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .